4.4 Article

Identification of Erythrocyte p55/MPP1 as a Binding Partner of NF2 Tumor Suppressor Protein/Merlin

Journal

EXPERIMENTAL BIOLOGY AND MEDICINE
Volume 234, Issue 3, Pages 255-262

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.3181/0809-RM-275

Keywords

erythrocyte p55; protein 4.1R; MPP1; MAGUK; FERM domain; merlin; schwannomin; NF2

Funding

  1. National Institutes of Health [HL60755, CA 94414]
  2. Department of Defense [NF020087]
  3. Italian Telethon
  4. Association Francaise contre les Myopathies (AFM)
  5. ERA-Net

Ask authors/readers for more resources

Neurofibromatosis type 2 is an inherited disorder characterized by the development of benign and malignant tumors on the auditory nerves and central nervous system with symptoms including hearing loss, poor balance, skin lesions, and cataracts. Here, we report a novel protein-protein interaction between NF2 protein (merlin or schwannomin) and erythrocyte p55, also designated as MPP1. The p55 is a conserved scaffolding protein with postulated functions in cell shape, hair cell development, and neural patterning of the retina. The FERM domain of NF2 protein binds directly to p55, and surface plasmon resonance analysis indicates a specific interaction with a kD value of 3.7 nM. We developed a specific monoclonal antibody against human erythrocyte p55, and found that both p55 and NF2 proteins are colocalized in the non-myelin-forming Schwann cells. This finding suggests that the p55-NF2 protein interaction may play a functional role in the regulation of apico-basal polarity and tumor suppression pathways in non-erythroid cells. Exp Biol Med 234:255-262, 2009

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available